Boule Diagnostics AB (publ) (STO:BOUL)
Sweden flag Sweden · Delayed Price · Currency is SEK
6.44
+0.24 (3.87%)
Aug 18, 2025, 5:29 PM CET
3.87%
Market Cap240.77M
Revenue (ttm)515.86M
Net Income (ttm)-319.68M
Shares Out38.83M
EPS (ttm)-8.22
PE Ration/a
Forward PE16.26
Dividendn/a
Ex-Dividend Daten/a
Volume28,840
Average Volume66,212
Open6.20
Previous Close6.20
Day's Range6.20 - 6.46
52-Week Range6.00 - 10.60
Beta0.39
RSI31.28
Earnings DateOct 24, 2025

About Boule Diagnostics AB

Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories... [Read more]

Sector Healthcare
Founded 1956
Employees 200
Stock Exchange Nasdaq Stockholm
Ticker Symbol BOUL
Full Company Profile

Financial Performance

Financial Statements

News

Boule Diagnostics AB (OSTO:BOUL) Q2 2025 Earnings Call Highlights: Navigating Challenges with ...

Boule Diagnostics AB (OSTO:BOUL) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth

4 weeks ago - GuruFocus

Q4 2024 Boule Diagnostics AB Earnings Call Transcript

Q4 2024 Boule Diagnostics AB Earnings Call Transcript

6 months ago - GuruFocus

Q3 2024 Boule Diagnostics AB Earnings Call Transcript

Q3 2024 Boule Diagnostics AB Earnings Call Transcript

10 months ago - GuruFocus